Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 30 studies | 26% ± 10% | |
classical monocyte | 27 studies | 51% ± 16% | |
non-classical monocyte | 23 studies | 38% ± 12% | |
monocyte | 21 studies | 38% ± 13% | |
neutrophil | 15 studies | 62% ± 20% | |
conventional dendritic cell | 14 studies | 25% ± 9% | |
myeloid cell | 10 studies | 29% ± 13% | |
dendritic cell | 9 studies | 31% ± 14% | |
alveolar macrophage | 6 studies | 27% ± 12% | |
intermediate monocyte | 4 studies | 68% ± 13% | |
microglial cell | 3 studies | 42% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 9 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4229.25 | 576 / 578 | 88% | 16.23 | 1012 / 1155 |
breast | 61% | 414.18 | 278 / 459 | 80% | 8.43 | 897 / 1118 |
brain | 34% | 279.05 | 899 / 2642 | 93% | 41.73 | 657 / 705 |
kidney | 47% | 305.67 | 42 / 89 | 79% | 13.91 | 710 / 901 |
adrenal gland | 77% | 532.61 | 199 / 258 | 40% | 3.88 | 91 / 230 |
bladder | 48% | 515.86 | 10 / 21 | 62% | 8.96 | 314 / 504 |
pancreas | 19% | 97.38 | 61 / 328 | 88% | 18.74 | 157 / 178 |
stomach | 36% | 345.76 | 131 / 359 | 70% | 9.95 | 200 / 286 |
intestine | 43% | 301.07 | 418 / 966 | 62% | 9.60 | 329 / 527 |
spleen | 100% | 10511.70 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 38% | 185.55 | 248 / 653 | 62% | 5.18 | 374 / 605 |
uterus | 35% | 220.66 | 60 / 170 | 64% | 6.30 | 296 / 459 |
lymph node | 0% | 0 | 0 / 0 | 97% | 59.99 | 28 / 29 |
ovary | 28% | 134.21 | 51 / 180 | 66% | 7.22 | 285 / 430 |
esophagus | 33% | 216.21 | 484 / 1445 | 58% | 4.49 | 106 / 183 |
skin | 23% | 109.73 | 419 / 1809 | 66% | 8.10 | 312 / 472 |
adipose | 82% | 1307.56 | 990 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 95524.39 | 755 / 929 | 0% | 0 | 0 / 0 |
liver | 49% | 308.10 | 111 / 226 | 31% | 2.68 | 126 / 406 |
prostate | 38% | 215.60 | 92 / 245 | 39% | 2.55 | 194 / 502 |
blood vessel | 71% | 702.12 | 943 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 6.80 | 29 / 45 |
heart | 50% | 322.18 | 428 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.28 | 5 / 80 |
muscle | 6% | 19.95 | 46 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0006935 | Biological process | chemotaxis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007263 | Biological process | nitric oxide mediated signal transduction |
GO_0002430 | Biological process | complement receptor mediated signaling pathway |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0004982 | Molecular function | N-formyl peptide receptor activity |
GO_0004875 | Molecular function | complement receptor activity |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0005124 | Molecular function | scavenger receptor binding |
GO_0050786 | Molecular function | RAGE receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FPR1 |
Protein name | fMet-Leu-Phe receptor (fMLP receptor) (N-formyl peptide receptor) (FPR) (N-formylpeptide chemoattractant receptor) fMet-Leu-Phe receptor |
Synonyms | |
Description | FUNCTION: High affinity receptor for N-formyl-methionyl peptides (fMLP), which are powerful neutrophil chemotactic factors . Binding of fMLP to the receptor stimulates intracellular calcium mobilization and superoxide anion release . This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system . Receptor for TAFA4, mediates its effects on chemoattracting macrophages, promoting phagocytosis and increasing ROS release . Receptor for cathepsin CTSG, leading to increased phagocyte chemotaxis . . |
Accessions | ENST00000594900.1 ENST00000600815.1 ENST00000594900.2 ENST00000304748.5 P21462 M0QZT0 ENST00000595042.5 ENST00000600815.2 M0R315 |